TARS vs AMGN: Which Stock is Better?
Side-by-side comparison of Tarsus Pharmaceuticals Inc and Amgen Inc in 2026
TARS
Tarsus Pharmaceuticals Inc
$67.72
AMGN
Amgen Inc
$349.39
Key Metrics Comparison
| Metric | TARS | AMGN | Winner |
|---|---|---|---|
| Market Cap | $3.06B | $187.71B | AMGN |
| P/E Ratio | N/A | 24.45 | AMGN |
| EPS (TTM) | $N/A | $14.24 | AMGN |
| Revenue Growth | 1.3% | 0.1% | TARS |
| Gross Margin | 79.0% | 70.8% | TARS |
Analyze TARS
Full quant analysis
Analyze AMGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is TARS or AMGN a better investment?
Comparing TARS and AMGN: Tarsus Pharmaceuticals Inc has a market cap of $3.06B while Amgen Inc has $187.71B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between TARS and AMGN?
TARS (Tarsus Pharmaceuticals Inc) and AMGN (Amgen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: TARS or AMGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: TARS or AMGN?
TARS has higher revenue growth at 1.3% vs 0.1% for AMGN.
Which company is more profitable: TARS or AMGN?
Tarsus Pharmaceuticals Inc (TARS) has higher gross margins at 79.0% compared to 70.8% for AMGN.
Which is the larger company: TARS or AMGN?
Amgen Inc (AMGN) is larger with a market cap of $187.71B compared to $3.06B for TARS.
Should I buy TARS or AMGN in 2026?
Both TARS and AMGN have investment merit. TARS trades at $67.72 while AMGN trades at $349.39. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between TARS and AMGN stock?
Key differences: Market Cap ($3.06B vs $187.71B), P/E Ratio (N/A vs 24.5x), Revenue Growth (1.3% vs 0.1%), Gross Margin (79.0% vs 70.8%).